Scientists hope they’re closing in on a cure for COVID-19

In the Race for a Covid-19 Pill, a Little Lab Plays a Big Role

Experimental drug from Emory could see immediate use in India COVID surge

Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19

Antios Therapeutics Raises $96 Million in a Series B Financing

Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173

Emory, collaborators testing antiviral drug as potential treatment for coronaviruses

New drug forces flu virus into ‘error catastrophe,’ overwhelming it with mutations

The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal Venezuelan equine encephalitis virus infection.

Drug Innovation Ventures at Emory (DRIVE) and Antios Therapeutics announce license for hepatitis B drug